National Institute of Allergy and Infectious Diseases

Government

US federal research institute (part of NIH) funding biotech and life science companies via SBIR/STTR grants to advance infectious disease, immunology, and allergy research.

National Institute of Allergy and Infectious Diseases was founded in 1955, is headquartered in Bethesda, United States, has 23 recorded investments, and includes 1 company in its recorded portfolio.

Pre-Seed
Seed
Biotech
Life Sciences
infectious_disease
Headquarters
Bethesda, United States
Founded
1955
Portfolio Company
1
Total Investments
23
Last Investment
Jul 2024
Geographic Focus
United States

Indexed holds 1 portfolio company and 23 funding rounds for this investor. The full record is or through the API.

Investment Thesis

Fund early-stage small businesses via SBIR/STTR grants to bridge basic science and commercialization of vaccines, therapeutics, diagnostics, and medical technologies.

National Institute of Allergy and Infectious Diseases is a Government firm based in Bethesda, United States. It was founded in 1955. It has made 23 investments, including BLUEWILLOW BIOLOGICS INC. Focus areas include Biotech and Life Sciences.

Portfolio1

Co-investors2

Sign up to view co-investors

2 co-investors across 1 shared portfolio company — who they back alongside, and how often they lead.

Venture Capital ×1 · Government ×1 · 2 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

National Institute of Allergy and Infectious Diseases on Indexed.vc
<a href="https://indexed.vc/investors/national-institute-of-allergy-and-infectious-diseases"><img src="https://indexed.vc/api/badge/investor/national-institute-of-allergy-and-infectious-diseases" alt="National Institute of Allergy and Infectious Diseases on Indexed.vc" width="260" height="76" /></a>